With budgets up yet again, industry marketers are drowning out the political noise and pouncing on the opportunities that present themselves.
While big tech’s promise to analyze America’s health data has tantalized and terrorized medical marketers, recent developments have pushed many players into a privacy panic.
[Stop us if you’ve heard this one] Egged on by brash, funny patients active in their online communities, pharma marketers are considering adding humor to their rhetorical toolbox.
Salaries are up and workers are largely content, but healthcare marketing’s troubling gender gap is getting worse.
Following an 8% jump in revenue during 2018, from $13.7 million to $14.8 million, HCB is off to a fast start in 2019.
Revenue surged 25% during 2018, to an MM&M-estimated $25 million.
MM&M estimates that FCB Health NY saw a 20.3% jump in revenue during 2018, to $219 million from an estimated $182 million in 2017.
ApotheCom’s addition of behavioral sciences to its slate of offerings is significant in that it marks another step in the company’s evolution.
